XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.25.3

SCHEDULE OF WARRANTS OUTSTANDING (Details) | 3 Months Ended
--- | ---
Oct. 31, 2025 $ / shares shares
Share Purchase Warrants [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 1,653,914 |
Number of warrants exercisable | 1,653,914 |
Share Purchase Warrants [Member] | Warrant One [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | (346) | [1]
Exercise Price | $ / shares | $ 588.62 |
Number of warrants exercisable | 346 |
Expiry Date | Nov. 16, 2025 |
Share Purchase Warrants [Member] | Warrant Two [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | (25,978) | [1]
Exercise Price | $ / shares | $ 796.88 |
Number of warrants exercisable | 25,978 |
Share Purchase Warrants [Member] | Warrant Two [Member] | Minimum [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Expiry Date | Feb. 26, 2026 |
Share Purchase Warrants [Member] | Warrant Two [Member] | Maximum [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Expiry Date | Apr. 26, 2026 |
Share Purchase Warrants [Member] | Warrant Three [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | (27,820) | [1]
Exercise Price | $ / shares | $ 928.50 |
Number of warrants exercisable | 27,820 |
Expiry Date | Dec. 07, 2026 |
Share Purchase Warrants [Member] | Warrant Four [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 16,019 |
Exercise Price | $ / shares | $ 316.50 |
Number of warrants exercisable | 16,019 |
Expiry Date | Nov. 17, 2029 |
Share Purchase Warrants [Member] | Warrant Five [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 27,753 |
Exercise Price | $ / shares | $ 127.50 |
Number of warrants exercisable | 27,753 |
Expiry Date | Oct. 02, 2029 |
Share Purchase Warrants [Member] | Warrant Six [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 49,333 |
Exercise Price | $ / shares | $ 140.63 |
Number of warrants exercisable | 49,333 |
Expiry Date | Dec. 12, 2029 |
Share Purchase Warrants [Member] | Warrant Seven [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 306,665 |
Exercise Price | $ / shares | $ 52.50 |
Number of warrants exercisable | 306,665 |
Expiry Date | Apr. 28, 2030 |
Share Purchase Warrants [Member] | Warrant Eight [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 1,200,000 |
Exercise Price | $ / shares | $ 15.00 |
Number of warrants exercisable | 1,200,000 |
Expiry Date | Jul. 15, 2030 |
Compensation Warrants [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 28,072 | [2]
Number of warrants exercisable | 28,072 |
Compensation Warrants [Member] | Warrant One [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | (34) | [2]
Exercise Price | $ / shares | $ 588.62 |
Number of warrants exercisable | 34 |
Expiry date | Nov. 16, 2025 |
Compensation Warrants [Member] | Warrant Two [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | (113) | [2]
Exercise Price | $ / shares | $ 796.88 |
Number of warrants exercisable | 113 |
Expiry date | Feb. 26, 2026 |
Compensation Warrants [Member] | Warrant Three [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | (164) | [2]
Exercise Price | $ / shares | $ 928.50 |
Number of warrants exercisable | 164 |
Expiry date | Jun. 07, 2026 |
Compensation Warrants [Member] | Warrant Four [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 333 |
Exercise Price | $ / shares | $ 348.00 |
Number of warrants exercisable | 333 |
Expiry date | May 17, 2029 |
Compensation Warrants [Member] | Warrant Five [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 4,108 | [2]
Exercise Price | $ / shares | $ 129.38 |
Number of warrants exercisable | 4,108 |
Expiry date | Sep. 12, 2029 |
Compensation Warrants [Member] | Warrant Six [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 1,709 | [2]
Exercise Price | $ / shares | $ 182.81 |
Number of warrants exercisable | 1,709 |
Expiry date | Oct. 02, 2029 |
Compensation Warrants [Member] | Warrant Seven [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 2,466 | [2]
Exercise Price | $ / shares | $ 140.63 |
Number of warrants exercisable | 2,466 |
Expiry date | Dec. 12, 2029 |
Compensation Warrants [Member] | Warrant Eight [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 3,812 | [2]
Exercise Price | $ / shares | $ 50.00 |
Number of warrants exercisable | 3,812 |
Expiry date | Feb. 05, 2030 |
Compensation Warrants [Member] | Warrant Nine [Member] |  |
Accumulated Other Comprehensive Income (Loss) [Line Items] |  |
Number of warrants outstanding | 15,333 | [2]
Exercise Price | $ / shares | $ 56.50 |
Number of warrants exercisable | 15,333 |
Expiry date | Apr. 28, 2030 |
[1] | Briacell Legacy Warrants – see note 1(e) and note 4(a)
[2] | Briacell Legacy Warrants – see note 1(e) and note 4(a)

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 17 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date the warrants or rights are exercisable, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_SharePurchaseWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_WarrantOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_WarrantTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_WarrantThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_WarrantFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_WarrantFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_WarrantSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_WarrantSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_WarrantEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_CompensationWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=BCTX_WarrantNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |